Advanced Search (OLGA)

Gene: CDCA5 (cell division cycle associated 5) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

CDCA5

Name:

cell division cycle associated 5

RGD ID:

1350338

HGNC Page

HGNC:14626

Description:

Predicted to enable chromatin binding activity. Involved in chromosome organization; double-strand break repair; and positive regulation of exit from mitosis. Located in nucleoplasm.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

cell division cycle-associated protein 5; MGC16386; p35; sororin

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	11	65,061,093 - 65,084,040 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	11	65,066,300 - 65,084,164 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	11	64,844,925 - 64,851,512 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	11	64,601,503 - 64,608,100 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	11	64,601,502 - 64,608,100	NCBI
Celera	11	62,171,226 - 62,177,913 (-)	NCBI		Celera
Cytogenetic Map	11	q13.1	NCBI
HuRef	11	61,171,560 - 61,178,247 (-)	NCBI		HuRef
CHM1_1	11	64,728,627 - 64,735,313 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	11	65,054,375 - 65,077,318 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	COVID-19		HEP		28912744	mRNA:increased expression:peripheral blood mononuclear cell (human)	RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	Bardet-Biedl syndrome		IAGP	RGD:151729098	8554872	ClinVar Annotator: match by term: Bardet-Biedl syndrome	ClinVar	PMID:12118255\|PMID:16786513\|PMID:21520335\|PMID:27032803\|PMID:28492532\|PMID:8316268
CDCA5	Human	glycogen storage disease V		IAGP	RGD:151729098	8554872	ClinVar Annotator: match by term: Glycogen storage disease, type V	ClinVar	PMID:12118255\|PMID:16786513\|PMID:21520335\|PMID:27032803\|PMID:28492532\|PMID:8316268
CDCA5	Human	intellectual disability		IAGP	RGD:42723466	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar
CDCA5	Human	leukocyte adhesion deficiency 3		IAGP	RGD:156443029	8554872	ClinVar Annotator: match by term: Leukocyte adhesion deficiency 3	ClinVar	PMID:28492532

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	hepatocellular carcinoma		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:28284560

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	1,1-dichloroethene	increases expression	ISO	RGD:1622313	6480464	vinylidene chloride results in increased expression of CDCA5 mRNA	CTD	PMID:26682919
CDCA5	Human	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1622313	6480464	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ...	CTD	PMID:25510870
CDCA5	Human	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622313	6480464	1,2-Dimethylhydrazine results in increased expression of CDCA5 mRNA	CTD	PMID:22206623
CDCA5	Human	17alpha-ethynylestradiol	affects expression	ISO	RGD:1622313	6480464	Ethinyl Estradiol affects the expression of CDCA5 mRNA	CTD	PMID:17555576
CDCA5	Human	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1622313	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA5 mRNA	CTD	PMID:17942748
CDCA5	Human	17alpha-ethynylestradiol	increases expression	ISO	RGD:1622313	6480464	Ethinyl Estradiol results in increased expression of CDCA5 mRNA	CTD	PMID:17942748
CDCA5	Human	17beta-estradiol	increases expression	ISO	RGD:1622313	6480464	Estradiol results in increased expression of CDCA5 mRNA	CTD	PMID:25210133
CDCA5	Human	17beta-estradiol	increases expression	EXP		6480464	Estradiol results in increased expression of CDCA5 mRNA	CTD	PMID:19167446\|PMID:20106945
CDCA5	Human	17beta-estradiol	multiple interactions	ISO	RGD:1622313	6480464	ESR1 protein promotes the reaction [Estradiol results in increased expression of CDCA5 mRNA]	CTD	PMID:25210133
CDCA5	Human	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1622313	6480464	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ...	CTD	PMID:25510870
CDCA5	Human	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1622313	6480464	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ...	CTD	PMID:25510870
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		6480464	Tetrachlorodibenzodioxin results in increased expression of CDCA5 mRNA	CTD	PMID:19684285
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622313	6480464	Tetrachlorodibenzodioxin affects the expression of CDCA5 mRNA	CTD	PMID:21570461\|PMID:23994337
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		6480464	Tetrachlorodibenzodioxin affects the expression of CDCA5 mRNA	CTD	PMID:22574217
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622313	6480464	Tetrachlorodibenzodioxin results in increased expression of CDCA5 mRNA	CTD	PMID:15328365\|PMID:16611356\|PMID:19684285\|PMID:19770486
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		6480464	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CDCA5 mRNA	CTD	PMID:19684285
CDCA5	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622313	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA5 mRNA	CTD	PMID:17942748
CDCA5	Human	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1622313	6480464	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ...	CTD	PMID:25510870
CDCA5	Human	2-palmitoylglycerol	increases expression	EXP		6480464	2-palmitoylglycerol results in increased expression of CDCA5 mRNA	CTD	PMID:37199045
CDCA5	Human	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1622313	6480464	3,4,5,3',4'-pentachlorobiphenyl affects the expression of CDCA5 mRNA	CTD	PMID:23994337
CDCA5	Human	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
CDCA5	Human	3-methylcholanthrene	increases expression	ISO	RGD:1622313	6480464	Methylcholanthrene results in increased expression of CDCA5 mRNA	CTD	PMID:20713471
CDCA5	Human	5-fluorouracil	increases expression	EXP		6480464	Fluorouracil results in increased expression of CDCA5 mRNA	CTD	PMID:16709241
CDCA5	Human	acetamide	increases expression	ISO	RGD:1560863	6480464	acetamide results in increased expression of CDCA5 mRNA	CTD	PMID:31881176
CDCA5	Human	acrylamide	increases expression	ISO	RGD:1560863	6480464	Acrylamide results in increased expression of CDCA5 mRNA	CTD	PMID:28959563
CDCA5	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of CDCA5 protein	CTD	PMID:20106945
CDCA5	Human	aflatoxin B1	increases expression	ISO	RGD:1622313	6480464	Aflatoxin B1 results in increased expression of CDCA5 mRNA	CTD	PMID:19770486
CDCA5	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of CDCA5 mRNA	CTD	PMID:33167477
CDCA5	Human	antimycin A	increases expression	EXP		6480464	Antimycin A results in increased expression of CDCA5 mRNA	CTD	PMID:33512557
CDCA5	Human	aristolochic acid A	increases expression	EXP		6480464	aristolochic acid I results in increased expression of CDCA5 mRNA	CTD	PMID:33212167
CDCA5	Human	arsane	multiple interactions	ISO	RGD:1622313	6480464	[APOE protein affects the susceptibility to Arsenic] which affects the expression of CDCA5 mRNA	CTD	PMID:22719926
CDCA5	Human	arsenic atom	multiple interactions	ISO	RGD:1622313	6480464	[APOE protein affects the susceptibility to Arsenic] which affects the expression of CDCA5 mRNA	CTD	PMID:22719926
CDCA5	Human	arsenite(3-)	multiple interactions	EXP		6480464	arsenite inhibits the reaction [G3BP1 protein binds to CDCA5 mRNA]	CTD	PMID:32406909
CDCA5	Human	azathioprine	decreases expression	EXP		6480464	Azathioprine results in decreased expression of CDCA5 mRNA	CTD	PMID:22623647
CDCA5	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of CDCA5 mRNA	CTD	PMID:20064835
CDCA5	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of CDCA5 mRNA	CTD	PMID:32234424
CDCA5	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of CDCA5 3' UTR	CTD	PMID:27901495
CDCA5	Human	benzo[a]pyrene	increases expression	ISO	RGD:1622313	6480464	Benzo(a)pyrene results in increased expression of CDCA5 mRNA	CTD	PMID:20504355\|PMID:20713471\|PMID:32417428
CDCA5	Human	benzo[a]pyrene	decreases expression	ISO	RGD:1622313	6480464	Benzo(a)pyrene results in decreased expression of CDCA5 mRNA	CTD	PMID:19770486
CDCA5	Human	benzo[a]pyrene diol epoxide I	increases expression	EXP		6480464	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CDCA5 mRNA	CTD	PMID:19150397
CDCA5	Human	benzo[a]pyrene diol epoxide I	decreases expression	EXP		6480464	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDCA5 mRNA	CTD	PMID:20382639
CDCA5	Human	benzo[b]fluoranthene	increases expression	ISO	RGD:1622313	6480464	benzo(b)fluoranthene results in increased expression of CDCA5 mRNA	CTD	PMID:26377693
CDCA5	Human	beta-naphthoflavone	affects expression	ISO	RGD:1622313	6480464	beta-Naphthoflavone affects the expression of CDCA5 mRNA	CTD	PMID:23994337
CDCA5	Human	bis(2-chloroethyl) sulfide	decreases expression	EXP		6480464	Mustard Gas results in decreased expression of CDCA5 mRNA	CTD	PMID:25102026
CDCA5	Human	bisphenol A	affects expression	ISO	RGD:1560863	6480464	bisphenol A affects the expression of CDCA5 mRNA	CTD	PMID:25181051
CDCA5	Human	bisphenol A	affects expression	EXP		6480464	bisphenol A affects the expression of CDCA5 mRNA	CTD	PMID:30903817
CDCA5	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of CDCA5 mRNA	CTD	PMID:29275510
CDCA5	Human	bisphenol A	multiple interactions	EXP		6480464	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects more ...	CTD	PMID:28628672\|PMID:33376534
CDCA5	Human	cadmium atom	decreases expression	EXP		6480464	Cadmium results in decreased expression of CDCA5 mRNA	CTD	PMID:21120746
CDCA5	Human	caffeine	decreases phosphorylation	EXP		6480464	Caffeine results in decreased phosphorylation of CDCA5 protein	CTD	PMID:35688186
CDCA5	Human	calcitriol	decreases expression	EXP		6480464	Calcitriol results in decreased expression of CDCA5 mRNA	CTD	PMID:21592394
CDCA5	Human	calcitriol	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of CDCA5 mRNA	CTD	PMID:21592394
CDCA5	Human	cannabidiol	decreases expression	EXP		6480464	Cannabidiol results in decreased expression of CDCA5 mRNA	CTD	PMID:36519830
CDCA5	Human	carbon nanotube	affects expression	ISO	RGD:1622313	6480464	Nanotubes, Carbon affects the expression of CDCA5 mRNA	CTD	PMID:25554681
CDCA5	Human	carbon nanotube	increases expression	ISO	RGD:1622313	6480464	Nanotubes, Carbon analog results in increased expression of CDCA5 mRNA	CTD	PMID:25554681
CDCA5	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to CDCA5 gene]	CTD	PMID:28238834
CDCA5	Human	choline	multiple interactions	ISO	RGD:1622313	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
CDCA5	Human	chromium(6+)	multiple interactions	EXP		6480464	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression more ...	CTD	PMID:38479592
CDCA5	Human	cisplatin	increases expression	EXP		6480464	Cisplatin results in increased expression of CDCA5 mRNA	CTD	PMID:27594783
CDCA5	Human	cisplatin	decreases expression	EXP		6480464	Cisplatin results in decreased expression of CDCA5 mRNA	CTD	PMID:27392435
CDCA5	Human	copper atom	increases expression	ISO	RGD:1560863	6480464	Copper deficiency results in increased expression of CDCA5 mRNA	CTD	PMID:26033743
CDCA5	Human	copper(0)	increases expression	ISO	RGD:1560863	6480464	Copper deficiency results in increased expression of CDCA5 mRNA	CTD	PMID:26033743
CDCA5	Human	coumarin	affects phosphorylation	EXP		6480464	coumarin affects the phosphorylation of CDCA5 protein	CTD	PMID:35688186
CDCA5	Human	coumestrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA; [Coumestrol co-treated with resveratrol] more ...	CTD	PMID:19167446
CDCA5	Human	coumestrol	increases expression	EXP		6480464	Coumestrol results in increased expression of CDCA5 mRNA	CTD	PMID:19167446
CDCA5	Human	cycloheximide	increases expression	EXP		6480464	Cycloheximide results in increased expression of CDCA5 mRNA	CTD	PMID:19684285
CDCA5	Human	cycloheximide	multiple interactions	EXP		6480464	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CDCA5 mRNA	CTD	PMID:19684285
CDCA5	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of CDCA5 mRNA	CTD	PMID:20106945\|PMID:21632981\|PMID:25562108
CDCA5	Human	DDE	increases expression	EXP		6480464	Dichlorodiphenyl Dichloroethylene results in increased expression of CDCA5 mRNA	CTD	PMID:38568856
CDCA5	Human	dexamethasone	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
CDCA5	Human	diazinon	affects expression	ISO	RGD:1560863	6480464	Diazinon affects the expression of CDCA5 mRNA	CTD	PMID:22546817
CDCA5	Human	dibenz[a,h]anthracene	increases expression	ISO	RGD:1622313	6480464	1,2,5,6-dibenzanthracene results in increased expression of CDCA5 mRNA	CTD	PMID:26377693
CDCA5	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of CDCA5 mRNA	CTD	PMID:37042841
CDCA5	Human	dibutyl phthalate	decreases expression	ISO	RGD:1622313	6480464	Dibutyl Phthalate results in decreased expression of CDCA5 mRNA	CTD	PMID:17361019\|PMID:21266533
CDCA5	Human	dibutyl phthalate	multiple interactions	EXP		6480464	N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CDCA5 mRNA]	CTD	PMID:36828243
CDCA5	Human	dibutyl phthalate	increases expression	EXP		6480464	Dibutyl Phthalate results in increased expression of CDCA5 mRNA	CTD	PMID:36828243
CDCA5	Human	diclofenac	increases expression	ISO	RGD:1622313	6480464	Diclofenac results in increased expression of CDCA5 mRNA	CTD	PMID:26934552
CDCA5	Human	dioxygen	decreases expression	EXP		6480464	Oxygen deficiency results in decreased expression of CDCA5 mRNA	CTD	PMID:26516004
CDCA5	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of CDCA5 mRNA	CTD	PMID:30031762
CDCA5	Human	endosulfan	increases expression	ISO	RGD:1560863	6480464	Endosulfan results in increased expression of CDCA5 mRNA	CTD	PMID:29391264
CDCA5	Human	Enterolactone	multiple interactions	EXP		6480464	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA	CTD	PMID:19167446
CDCA5	Human	folic acid	multiple interactions	ISO	RGD:1622313	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
CDCA5	Human	FR900359	affects phosphorylation	EXP		6480464	FR900359 affects the phosphorylation of CDCA5 protein	CTD	PMID:37730182
CDCA5	Human	genistein	affects expression	EXP		6480464	Genistein affects the expression of CDCA5 mRNA	CTD	PMID:18847459
CDCA5	Human	indometacin	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ...	CTD	PMID:28628672
CDCA5	Human	ivermectin	decreases expression	EXP		6480464	Ivermectin results in decreased expression of CDCA5 protein	CTD	PMID:32959892
CDCA5	Human	L-methionine	multiple interactions	ISO	RGD:1622313	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ...	CTD	PMID:20938992
CDCA5	Human	leflunomide	decreases expression	EXP		6480464	leflunomide results in decreased expression of CDCA5 mRNA	CTD	PMID:28988120
CDCA5	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of CDCA5 mRNA	CTD	PMID:20044591
CDCA5	Human	methyl methanesulfonate	increases expression	EXP		6480464	Methyl Methanesulfonate results in increased expression of CDCA5 mRNA	CTD	PMID:23649840
CDCA5	Human	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1622313	6480464	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA5 mRNA]	CTD	PMID:17854601
CDCA5	Human	N-nitrosodiethylamine	increases expression	ISO	RGD:1622313	6480464	Diethylnitrosamine results in increased expression of CDCA5 mRNA	CTD	PMID:17854601
CDCA5	Human	nickel atom	increases expression	EXP		6480464	Nickel results in increased expression of CDCA5 mRNA	CTD	PMID:25583101
CDCA5	Human	nickel dichloride	affects expression	ISO	RGD:1560863	6480464	nickel chloride affects the expression of CDCA5 mRNA	CTD	PMID:22546817
CDCA5	Human	niclosamide	decreases expression	EXP		6480464	Niclosamide results in decreased expression of CDCA5 mRNA	CTD	PMID:28284560
CDCA5	Human	okadaic acid	increases expression	EXP		6480464	Okadaic Acid results in increased expression of CDCA5 mRNA	CTD	PMID:38832940
CDCA5	Human	ozone	multiple interactions	ISO	RGD:1622313	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ...	CTD	PMID:25658374\|PMID:27106289\|PMID:34911549
CDCA5	Human	ozone	increases expression	ISO	RGD:1622313	6480464	Ozone results in increased expression of CDCA5 mRNA	CTD	PMID:33026818
CDCA5	Human	palbociclib	decreases expression	EXP		6480464	palbociclib results in decreased expression of CDCA5 mRNA	CTD	PMID:22869556
CDCA5	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of CDCA5 mRNA	CTD	PMID:22230336
CDCA5	Human	paracetamol	increases expression	ISO	RGD:1560863	6480464	Acetaminophen results in increased expression of CDCA5 mRNA	CTD	PMID:33387578
CDCA5	Human	PCB138	multiple interactions	ISO	RGD:1622313	6480464	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ...	CTD	PMID:25510870
CDCA5	Human	perfluorooctanoic acid	multiple interactions	EXP		6480464	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] more ...	CTD	PMID:33325755
CDCA5	Human	perfluorooctanoic acid	decreases expression	EXP		6480464	perfluorooctanoic acid results in decreased expression of CDCA5 mRNA	CTD	PMID:36326898
CDCA5	Human	phenobarbital	affects expression	ISO	RGD:1622313	6480464	Phenobarbital affects the expression of CDCA5 mRNA	CTD	PMID:23091169
CDCA5	Human	phenobarbital	increases expression	ISO	RGD:1622313	6480464	Phenobarbital results in increased expression of CDCA5 mRNA	CTD	PMID:20403969\|PMID:23091169
CDCA5	Human	phytoestrogen	multiple interactions	EXP		6480464	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] more ...	CTD	PMID:33325755
CDCA5	Human	pirinixic acid	multiple interactions	ISO	RGD:1622313	6480464	PPARA protein promotes the reaction [pirinixic acid results in increased expression of CDCA5 mRNA]	CTD	PMID:17950772
CDCA5	Human	pirinixic acid	increases expression	ISO	RGD:1622313	6480464	pirinixic acid results in increased expression of CDCA5 mRNA	CTD	PMID:17950772\|PMID:23811191
CDCA5	Human	potassium dichromate	increases expression	EXP		6480464	Potassium Dichromate results in increased expression of CDCA5 protein	CTD	PMID:23718831
CDCA5	Human	propanal	decreases expression	EXP		6480464	propionaldehyde results in decreased expression of CDCA5 mRNA	CTD	PMID:26079696
CDCA5	Human	quercetin	increases expression	EXP		6480464	Quercetin results in increased expression of CDCA5 mRNA	CTD	PMID:21632981
CDCA5	Human	resveratrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with resveratrol] results in increased expression of CDCA5 mRNA	CTD	PMID:19167446
CDCA5	Human	silicon dioxide	increases expression	ISO	RGD:1622313	6480464	Silicon Dioxide results in increased expression of CDCA5 mRNA	CTD	PMID:29341224
CDCA5	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of CDCA5 mRNA	CTD	PMID:29301061\|PMID:34032870
CDCA5	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of CDCA5 mRNA	CTD	PMID:38568856
CDCA5	Human	sunitinib	decreases expression	EXP		6480464	Sunitinib results in decreased expression of CDCA5 mRNA	CTD	PMID:31533062
CDCA5	Human	T-2 toxin	increases expression	ISO	RGD:1560863	6480464	T-2 Toxin results in increased expression of CDCA5 mRNA	CTD	PMID:26141394
CDCA5	Human	tacrolimus hydrate	increases expression	ISO	RGD:1622313	6480464	Tacrolimus results in increased expression of CDCA5 mRNA	CTD	PMID:29362864
CDCA5	Human	testosterone	decreases expression	EXP		6480464	Testosterone results in decreased expression of CDCA5 mRNA	CTD	PMID:21592394
CDCA5	Human	testosterone	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of CDCA5 mRNA	CTD	PMID:21592394
CDCA5	Human	tetrachloromethane	increases expression	ISO	RGD:1622313	6480464	Carbon Tetrachloride results in increased expression of CDCA5 mRNA	CTD	PMID:17484886\|PMID:31919559
CDCA5	Human	thioacetamide	increases expression	ISO	RGD:1560863	6480464	Thioacetamide results in increased expression of CDCA5 mRNA	CTD	PMID:34492290
CDCA5	Human	titanium dioxide	increases expression	ISO	RGD:1622313	6480464	titanium dioxide results in increased expression of CDCA5 mRNA	CTD	PMID:23557971
CDCA5	Human	titanium dioxide	decreases methylation	ISO	RGD:1622313	6480464	titanium dioxide results in decreased methylation of CDCA5 gene	CTD	PMID:35295148
CDCA5	Human	trichloroethene	increases expression	ISO	RGD:1622313	6480464	Trichloroethylene results in increased expression of CDCA5 mRNA	CTD	PMID:25549359
CDCA5	Human	trimellitic anhydride	increases expression	ISO	RGD:1622313	6480464	trimellitic anhydride results in increased expression of CDCA5 mRNA	CTD	PMID:19042947
CDCA5	Human	troglitazone	decreases expression	EXP		6480464	troglitazone results in decreased expression of CDCA5 mRNA	CTD	PMID:19140230
CDCA5	Human	trovafloxacin	decreases expression	ISO	RGD:1622313	6480464	trovafloxacin results in decreased expression of CDCA5 mRNA	CTD	PMID:35537566
CDCA5	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of CDCA5 mRNA	CTD	PMID:28818685
CDCA5	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of CDCA5 mRNA	CTD	PMID:19101580
CDCA5	Human	valproic acid	decreases expression	ISO	RGD:1622313	6480464	Valproic Acid results in decreased expression of CDCA5 mRNA	CTD	PMID:21427059
CDCA5	Human	zinc atom	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of CDCA5 mRNA	CTD	PMID:18593933
CDCA5	Human	zinc atom	increases expression	EXP		6480464	Zinc deficiency results in increased expression of CDCA5 mRNA	CTD	PMID:22171008
CDCA5	Human	zinc(0)	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of CDCA5 mRNA	CTD	PMID:18593933
CDCA5	Human	zinc(0)	increases expression	EXP		6480464	Zinc deficiency results in increased expression of CDCA5 mRNA	CTD	PMID:22171008
CDCA5	Human	zoledronic acid	increases expression	EXP		6480464	zoledronic acid results in increased expression of CDCA5 protein	CTD	PMID:28871336

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	cell division	involved_in	IEA	UniProtKB-KW:KW-0132	150520179		UniProt	GO_REF:0000043
CDCA5	Human	double-strand break repair	involved_in	IMP		150520179	PMID:17349791	UniProt	PMID:17349791
CDCA5	Human	double-strand break repair	involved_in	IBA	PANTHER:PTN002828026\|UniProtKB:Q96FF9	150520179		GO_Central	GO_REF:0000033
CDCA5	Human	mitotic cell cycle	involved_in	ISO	RGD:1622313	9068941	PMID:15837422	UniProt	PMID:15837422
CDCA5	Human	mitotic metaphase chromosome alignment	involved_in	IBA	PANTHER:PTN002828026\|UniProtKB:Q96FF9	150520179		GO_Central	GO_REF:0000033
CDCA5	Human	mitotic sister chromatid cohesion	involved_in	IPI	UniProtKB:Q29RF7	150520179	PMID:21111234	UniProt	PMID:21111234
CDCA5	Human	mitotic sister chromatid cohesion	involved_in	IMP		150520179	PMID:15837422, PMID:17349791, PMID:21111234	UniProt	PMID:15837422\|PMID:17349791\|PMID:21111234
CDCA5	Human	mitotic sister chromatid cohesion	involved_in	IBA	MGI:1915099\|PANTHER:PTN002828026\|UniProtKB:A0A8J0V071\|UniProtKB:Q96FF9	150520179		GO_Central	GO_REF:0000033
CDCA5	Human	mitotic sister chromatid cohesion	involved_in	IEA	UniProtKB:Q9CPY3\|ensembl:ENSMUSP00000025704	150520179		Ensembl	GO_REF:0000107
CDCA5	Human	positive regulation of exit from mitosis	involved_in	IBA	PANTHER:PTN002828026\|UniProtKB:Q96FF9	150520179		GO_Central	GO_REF:0000033

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	chromatin	located_in	ISS	UniProtKB:Q9CPY3	150520179		UniProt	GO_REF:0000024
CDCA5	Human	chromatin	located_in	IEA	UniProtKB:Q9CPY3\|ensembl:ENSMUSP00000025704	150520179		Ensembl	GO_REF:0000107
CDCA5	Human	chromosome	located_in	TAS		150520179		Reactome	Reactome:R-HSA-2466068\|Reactome:R-HSA-2467794\|Reactome:R-HSA-2468041\|Reactome:R-HSA-2468293
CDCA5	Human	chromosome	located_in	IEA	UniProtKB-KW:KW-0158	150520179		UniProt	GO_REF:0000043
CDCA5	Human	chromosome	located_in	IEA	UniProtKB-SubCell:SL-0468	150520179		UniProt	GO_REF:0000044
CDCA5	Human	chromosome, centromeric region	located_in	TAS		150520179		Reactome	Reactome:R-HSA-1638803\|Reactome:R-HSA-1638821\|Reactome:R-HSA-2467809\|Reactome:R-HSA-2467811\|Reactome:R-HSA-2468287\|Reactome:R-HSA-2473151\|Reactome:R-HSA-2484822
CDCA5	Human	cytoplasm	located_in	IEA	UniProtKB-SubCell:SL-0086	150520179		UniProt	GO_REF:0000044
CDCA5	Human	cytoplasm	located_in	IEA	UniProtKB:Q9CPY3\|ensembl:ENSMUSP00000025704	150520179		Ensembl	GO_REF:0000107
CDCA5	Human	cytoplasm	located_in	IEA	UniProtKB-KW:KW-0963	150520179		UniProt	GO_REF:0000043
CDCA5	Human	cytoplasm	located_in	ISS	UniProtKB:Q9CPY3	150520179		UniProt	GO_REF:0000024
CDCA5	Human	cytosol	located_in	TAS		150520179		Reactome	Reactome:R-HSA-2467794\|Reactome:R-HSA-2467811
CDCA5	Human	nucleoplasm	located_in	IDA		150520179		HPA	GO_REF:0000052
CDCA5	Human	nucleoplasm	located_in	TAS		150520179		Reactome	Reactome:R-HSA-2468041\|Reactome:R-HSA-2473151
CDCA5	Human	nucleus	located_in	IEA	UniProtKB:Q9CPY3\|ensembl:ENSMUSP00000025704	150520179		Ensembl	GO_REF:0000107
CDCA5	Human	nucleus	is_active_in	IBA	MGI:1915099\|PANTHER:PTN002828026\|UniProtKB:Q96FF9	150520179		GO_Central	GO_REF:0000033
CDCA5	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044
CDCA5	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043
CDCA5	Human	nucleus	located_in	ISS	UniProtKB:Q9CPY3	150520179		UniProt	GO_REF:0000024

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	chromatin binding	enables	TAS		150520179	PMID:15837422	UniProt	PMID:15837422
CDCA5	Human	protein binding	enables	IPI	UniProtKB:P41227\|UniProtKB:Q14683	150520179	PMID:33961781	IntAct	PMID:33961781
CDCA5	Human	protein binding	enables	IPI	UniProtKB:P41227\|UniProtKB:Q9BSU3	150520179	PMID:32296183	IntAct	PMID:32296183
CDCA5	Human	protein binding	enables	IPI	UniProtKB:Q14683\|UniProtKB:Q5FBB7	150520179	PMID:23242214	IntAct	PMID:23242214
CDCA5	Human	protein binding	enables	IPI	UniProtKB:Q29RF7	150520179	PMID:21111234	IntAct	PMID:21111234
CDCA5	Human	protein binding	enables	IPI	UniProtKB:Q29RF7\|UniProtKB:Q9NTI5	150520179	PMID:21111234	UniProt	PMID:21111234
CDCA5	Human	protein binding	enables	IPI	UniProtKB:Q14683\|UniProtKB:Q29RF7	150520179	PMID:26496610	IntAct	PMID:26496610
CDCA5	Human	protein binding	enables	IPI	UniProtKB:Q14683	150520179	PMID:22885700, PMID:35271311	IntAct	PMID:22885700\|PMID:35271311
CDCA5	Human	protein-containing complex binding	enables	IDA		150520179	PMID:15837422	UniProt	PMID:15837422

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
CDCA5	Human	Ependymoma		IAGP	RGD:14695619	8554872	ClinVar Annotator: match by term: Ependymoma	ClinVar
CDCA5	Human	Intellectual disability		IAGP	RGD:42723466	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
4.	Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.	Xiong Y, etal., Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.

PMID:11111111	PMID:12188893	PMID:12477932	PMID:14702039	PMID:15146197	PMID:15489334	PMID:15837422	PMID:16169070	PMID:16964243	PMID:17081983	PMID:17349791	PMID:17361102
PMID:18029348	PMID:20360068	PMID:20379614	PMID:20551060	PMID:21111234	PMID:21115494	PMID:21873635	PMID:21987589	PMID:21988832	PMID:22833568	PMID:22885700	PMID:22939629
PMID:23242214	PMID:23455924	PMID:23548868	PMID:23901111	PMID:24098701	PMID:24999758	PMID:25092791	PMID:25257309	PMID:25281560	PMID:25608232	PMID:26177583	PMID:26186194
PMID:26496610	PMID:26497678	PMID:26895426	PMID:26951638	PMID:28514442	PMID:29117863	PMID:29326043	PMID:29383807	PMID:29452217	PMID:29724914	PMID:30015982	PMID:30497429
PMID:30657957	PMID:30804502	PMID:31010829	PMID:31068217	PMID:31180492	PMID:31586073	PMID:32203420	PMID:32296183	PMID:32694239	PMID:32759885	PMID:33639053	PMID:33650660
PMID:33770322	PMID:33961781	PMID:34077004	PMID:34079125	PMID:34189442	PMID:34509929	PMID:34597346	PMID:35271311	PMID:35373420	PMID:35506437	PMID:35509067	PMID:35642672
PMID:35973513	PMID:36004470	PMID:36373674	PMID:36424410	PMID:37247719	PMID:37689310	PMID:38539247	PMID:38978058

CDCA5
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	11	65,061,093 - 65,084,040 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	11	65,066,300 - 65,084,164 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	11	64,844,925 - 64,851,512 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	11	64,601,503 - 64,608,100 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	11	64,601,502 - 64,608,100	NCBI
Celera	11	62,171,226 - 62,177,913 (-)	NCBI		Celera
Cytogenetic Map	11	q13.1	NCBI
HuRef	11	61,171,560 - 61,178,247 (-)	NCBI		HuRef
CHM1_1	11	64,728,627 - 64,735,313 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	11	65,054,375 - 65,077,318 (-)	NCBI		T2T-CHM13v2.0

Cdca5
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	19	6,135,127 - 6,141,803 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	19	6,135,013 - 6,141,807 (+)	Ensembl		GRCm39 Ensembl
GRCm38	19	6,085,097 - 6,091,773 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	19	6,084,983 - 6,091,777 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	19	6,085,097 - 6,091,773 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	19	6,085,097 - 6,091,773 (+)	NCBI		MGSCv36	mm8
Celera	19	5,957,560 - 5,964,236 (+)	NCBI		Celera
Cytogenetic Map	19	A	NCBI
cM Map	19	4.34	NCBI

Cdca5
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	1	212,807,863 - 212,821,313 (+)	NCBI		GRCr8
mRatBN7.2	1	203,378,550 - 203,392,027 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	1	203,378,577 - 203,392,023 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	1	211,731,627 - 211,745,181 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	1	218,823,942 - 218,837,392 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	1	211,515,011 - 211,528,461 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	1	221,448,661 - 221,462,235 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	1	221,448,661 - 221,462,233 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	1	228,384,097 - 228,394,997 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	1	210,247,351 - 210,247,881 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	1	200,912,264 - 200,925,714 (+)	NCBI		Celera
Cytogenetic Map	1	q43	NCBI

Cdca5
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0	NW_004955422	20,114,565 - 20,129,679 (+)	NCBI	ChiLan1.0	ChiLan1.0

CDCA5
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	18	52,115,081 - 52,129,223 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	18	52,115,203 - 52,120,817 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	18	50,723,160 - 50,736,970 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	18	53,156,720 - 53,170,506 (+)	NCBI		ROS_Cfam_1.0
UMICH_Zoey_3.1	18	52,251,940 - 52,258,937 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	18	51,825,978 - 51,839,752 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	18	52,620,789 - 52,634,766 (+)	NCBI		UU_Cfam_GSD_1.0

Cdca5
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404947	7,842,550 - 7,856,508 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936599	4,284,958 - 4,291,874 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936599	4,285,007 - 4,291,875 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

CDCA5
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	2	7,103,673 - 7,113,202 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	2	7,103,648 - 7,112,772 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	2	6,235,704 - 6,251,945 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

CDCA5
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	1	9,151,503 - 9,157,412 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	1	9,151,712 - 9,157,456 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666038	106,533,173 - 106,538,620 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Cdca5
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla 1.0	NW_004624767	21,321,286 - 21,327,780 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in CDCA5
21 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_006782.3(ZFPL1):c.214+63C>T	single nucleotide variant	Malignant melanoma [RCV000069603]	Chr11:65085289 [GRCh38] Chr11:64852761 [GRCh37] Chr11:64609337 [NCBI36] Chr11:11q13.1	not provided
NM_006782.3(ZFPL1):c.439C>T (p.Pro147Ser)	single nucleotide variant	Malignant melanoma [RCV000069604]	Chr11:65086750 [GRCh38] Chr11:64854222 [GRCh37] Chr11:64610798 [NCBI36] Chr11:11q13.1	not provided
GRCh37/hg19 11q13.1-13.2(chr11:64501919-67129258)x3	copy number gain	See cases [RCV000511632]	Chr11:64501919..67129258 [GRCh37] Chr11:11q13.1-13.2	likely pathogenic
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)	copy number gain	See cases [RCV000511729]	Chr11:230616..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)x3	copy number gain	See cases [RCV000510881]	Chr11:230616..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
NM_080668.4(CDCA5):c.667C>T (p.Pro223Ser)	single nucleotide variant	not specified [RCV004320221]	Chr11:65079364 [GRCh38] Chr11:64846836 [GRCh37] Chr11:11q13.1	uncertain significance
GRCh37/hg19 11p15.5-q25(chr11:198510-134934063)x3	copy number gain	not provided [RCV000737348]	Chr11:198510..134934063 [GRCh37] Chr11:11p15.5-q25	pathogenic
GRCh37/hg19 11p15.5-q25(chr11:70864-134938470)x3	copy number gain	not provided [RCV000749874]	Chr11:70864..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
NM_080668.4(CDCA5):c.654G>A (p.Lys218=)	single nucleotide variant	not provided [RCV000881471]	Chr11:65079377 [GRCh38] Chr11:64846849 [GRCh37] Chr11:11q13.1	likely benign
NM_080668.4(CDCA5):c.360T>A (p.Pro120=)	single nucleotide variant	not provided [RCV000903647]	Chr11:65079671 [GRCh38] Chr11:64847143 [GRCh37] Chr11:11q13.1	benign
NM_080668.4(CDCA5):c.367G>A (p.Glu123Lys)	single nucleotide variant	not provided [RCV000893617]	Chr11:65079664 [GRCh38] Chr11:64847136 [GRCh37] Chr11:11q13.1	benign
dup(11)(q13.1q13.1)	duplication	Ependymoma [RCV000785872]	Chr11:63533279..65429676 [GRCh37] Chr11:11q13.1	likely pathogenic
GRCh37/hg19 11q13.1(chr11:64396501-64883447)x3	copy number gain	not provided [RCV000848683]	Chr11:64396501..64883447 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.243+10C>T	single nucleotide variant	not provided [RCV000886713]	Chr11:65083354 [GRCh38] Chr11:64850826 [GRCh37] Chr11:11q13.1	likely benign
NM_080668.4(CDCA5):c.519G>A (p.Gly173=)	single nucleotide variant	not provided [RCV000974100]	Chr11:65079512 [GRCh38] Chr11:64846984 [GRCh37] Chr11:11q13.1	benign
NM_080668.4(CDCA5):c.535G>A (p.Gly179Arg)	single nucleotide variant	not provided [RCV000962174]	Chr11:65079496 [GRCh38] Chr11:64846968 [GRCh37] Chr11:11q13.1	benign
NM_080668.4(CDCA5):c.315A>G (p.Thr105=)	single nucleotide variant	not provided [RCV000889069]	Chr11:65079716 [GRCh38] Chr11:64847188 [GRCh37] Chr11:11q13.1	benign
NC_000011.9:g.(?_59596957)_(68707199_?)dup	duplication	Familial temporal lobe epilepsy 8 [RCV001372442]	Chr11:59596957..68707199 [GRCh37] Chr11:11q12.1-13.3	uncertain significance
Single allele	deletion	Intellectual disability [RCV001293382]	Chr11:118359328..118372573 [GRCh37] Chr11:11p15.3-q23.3	pathogenic
NC_000011.9:g.(?_64522783)_(66283694_?)del	deletion	Bardet-Biedl syndrome [RCV002014493]\|Glycogen storage disease, type V [RCV002004587]	Chr11:64522783..66283694 [GRCh37] Chr11:11q13.1-13.2	pathogenic
NC_000011.9:g.(?_58916346)_(64972349_?)dup	duplication	Leukocyte adhesion deficiency 3 [RCV003113394]\|not provided [RCV003113393]	Chr11:58916346..64972349 [GRCh37] Chr11:11q12.1-13.1	uncertain significance\|no classifications from unflagged records
GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3	copy number gain	MISSED ABORTION [RCV002282973]	Chr11:32799481..134938470 [GRCh37] Chr11:11p13-q25	pathogenic
NM_080668.4(CDCA5):c.683C>T (p.Thr228Met)	single nucleotide variant	not specified [RCV004115978]	Chr11:65079183 [GRCh38] Chr11:64846655 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.508G>A (p.Gly170Arg)	single nucleotide variant	not specified [RCV004098128]	Chr11:65079523 [GRCh38] Chr11:64846995 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.505G>A (p.Glu169Lys)	single nucleotide variant	not specified [RCV004107551]	Chr11:65079526 [GRCh38] Chr11:64846998 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.325C>T (p.Pro109Ser)	single nucleotide variant	not specified [RCV004078757]	Chr11:65079706 [GRCh38] Chr11:64847178 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.217G>T (p.Val73Phe)	single nucleotide variant	not specified [RCV004227069]	Chr11:65083390 [GRCh38] Chr11:64850862 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.10A>G (p.Arg4Gly)	single nucleotide variant	not specified [RCV004150070]	Chr11:65083969 [GRCh38] Chr11:64851441 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.687G>C (p.Glu229Asp)	single nucleotide variant	not specified [RCV004258972]	Chr11:65079179 [GRCh38] Chr11:64846651 [GRCh37] Chr11:11q13.1	uncertain significance
GRCh37/hg19 11q12.2-13.5(chr11:59923608-76272324)x3	copy number gain	not provided [RCV003484842]	Chr11:59923608..76272324 [GRCh37] Chr11:11q12.2-13.5	pathogenic
GRCh37/hg19 11q13.1(chr11:64573225-65193732)x3	copy number gain	not provided [RCV003484844]	Chr11:64573225..65193732 [GRCh37] Chr11:11q13.1	uncertain significance
GRCh37/hg19 11q12.1-13.3(chr11:56895955-69295402)x3	copy number gain	not specified [RCV003986944]	Chr11:56895955..69295402 [GRCh37] Chr11:11q12.1-13.3	likely pathogenic
NM_080668.4(CDCA5):c.359C>G (p.Pro120Arg)	single nucleotide variant	not specified [RCV004606781]	Chr11:65079672 [GRCh38] Chr11:64847144 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.554G>C (p.Cys185Ser)	single nucleotide variant	not specified [RCV004901463]	Chr11:65079477 [GRCh38] Chr11:64846949 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.713A>T (p.Asn238Ile)	single nucleotide variant	not specified [RCV004901462]	Chr11:65079153 [GRCh38] Chr11:64846625 [GRCh37] Chr11:11q13.1	uncertain significance
NM_080668.4(CDCA5):c.556T>G (p.Ser186Ala)	single nucleotide variant	not specified [RCV004901461]	Chr11:65079475 [GRCh38] Chr11:64846947 [GRCh37] Chr11:11q13.1	uncertain significance

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR331	hsa-miR-331-3p	Mirecords	external_info	{changed}	NA	19996289

Predicted Target Of

	Summary Value
Count of predictions:	4239
Count of miRNA genes:	1125
Interacting mature miRNAs:	1403
Transcripts:	ENST00000275517, ENST00000404147, ENST00000438878, ENST00000462902, ENST00000479032, ENST00000524733, ENST00000525464, ENST00000527430, ENST00000529290, ENST00000531401, ENST00000533015
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
1357380	BW64_H	Body weight QTL 64 (human)	2.2		Body weight	percent fat after exercise training	11	60978937	86978937	Human
597368344	GWAS1464418_H	metabolic syndrome QTL GWAS1464418 (human)		5e-10	metabolic syndrome		11	65061370	65061371	Human
597517131	GWAS1613205_H	urate measurement QTL GWAS1613205 (human)		5e-21	urate measurement	blood uric acid level (CMO:0000501)	11	65071361	65071362	Human
597381027	GWAS1477101_H	Red cell distribution width QTL GWAS1477101 (human)		4e-08	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	11	65076787	65076788	Human
597383617	GWAS1479691_H	cardiovascular disease QTL GWAS1479691 (human)		5e-08	cardiovascular disease		11	65067943	65067944	Human
596957817	GWAS1077336_H	Red cell distribution width QTL GWAS1077336 (human)		4e-08	Red cell distribution width		11	65076787	65076788	Human
407382134	GWAS1031110_H	obsolete_red blood cell distribution width QTL GWAS1031110 (human)		4e-08	obsolete_red blood cell distribution width		11	65076787	65076788	Human
597486723	GWAS1582797_H	gut microbiome measurement QTL GWAS1582797 (human)		3e-08	gut microbiome measurement		11	65065819	65065820	Human

A002B21

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	64,845,024 - 64,845,130	UniSTS	GRCh37
Build 36	11	64,601,600 - 64,601,706	RGD	NCBI36
Celera	11	62,171,323 - 62,171,429	RGD
Cytogenetic Map	11	q12.1	UniSTS
HuRef	11	61,171,657 - 61,171,763	UniSTS
GeneMap99-GB4 RH Map	11	237.91	UniSTS
NCBI RH Map	11	573.2	UniSTS

WI-21617

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	64,844,931 - 64,845,193	UniSTS	GRCh37
Build 36	11	64,601,507 - 64,601,769	RGD	NCBI36
Celera	11	62,171,230 - 62,171,492	RGD
Cytogenetic Map	11	q12.1	UniSTS
HuRef	11	61,171,564 - 61,171,826	UniSTS
GeneMap99-GB4 RH Map	11	238.01	UniSTS
Whitehead-RH Map	11	316.9	UniSTS
NCBI RH Map	11	573.2	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2432	2788	2245	4947	1723	2345	4	622	1947	464	2268	7278	6452	52	3713	846	1732	1612	171


RefSeq Transcripts	NM_001433518	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_080668	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005273733	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005273734	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011544743	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011544747	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011544748	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011544749	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017017158	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367584	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367585	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367586	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367587	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367588	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367589	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367590	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001747757	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001747758	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_008488336	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_008488337	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB231703	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK093670	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK291490	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL832526	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AP003068	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC011000	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471076	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CN332525	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068267	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000275517 ⟹ ENSP00000275517

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,077,453 - 65,084,040 (-)	Ensembl

Ensembl Acc Id:

ENST00000404147 ⟹ ENSP00000385711

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,079,088 - 65,084,047 (-)	Ensembl

Ensembl Acc Id:

ENST00000462902

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,083,250 - 65,083,896 (-)	Ensembl

Ensembl Acc Id:

ENST00000479032

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,079,132 - 65,084,039 (-)	Ensembl

Ensembl Acc Id:

ENST00000524733 ⟹ ENSP00000431888

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,078,633 - 65,083,531 (-)	Ensembl

Ensembl Acc Id:

ENST00000525464 ⟹ ENSP00000432342

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,066,365 - 65,079,415 (-)	Ensembl

Ensembl Acc Id:

ENST00000527430 ⟹ ENSP00000432621

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,079,166 - 65,083,977 (-)	Ensembl

Ensembl Acc Id:

ENST00000529290 ⟹ ENSP00000432183

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,066,300 - 65,079,389 (-)	Ensembl

Ensembl Acc Id:

ENST00000531401

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,079,141 - 65,084,164 (-)	Ensembl

Ensembl Acc Id:

ENST00000533015

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	65,068,044 - 65,083,900 (-)	Ensembl

RefSeq Acc Id:

NM_080668 ⟹ NP_542399

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,077,453 - 65,084,040 (-)	NCBI
GRCh37	11	64,833,772 - 64,851,635 (-)	NCBI
Build 36	11	64,601,503 - 64,608,100 (-)	NCBI Archive
Celera	11	62,171,226 - 62,177,913 (-)	RGD
HuRef	11	61,171,560 - 61,178,247 (-)	ENTREZGENE
CHM1_1	11	64,728,627 - 64,735,313 (-)	NCBI
T2T-CHM13v2.0	11	65,070,734 - 65,077,318 (-)	NCBI

Sequence:

show sequence

CTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTGGAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCT
ACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGCTCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGC
CCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCGCAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCG
TCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACCCTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAG
ACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGCCGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAG
GGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCTCCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGAAAACGGAGCTGGATGAGTGGGCTGCGG
CCATGAATGCCGAGTTTGAAGCTGCTGAGCAGTTTGATCTCCTGGTTGAATGAGATGCAGTGGGGGGTGCACCTGGCCAGACTCTCCCTCCTGTCCTGTACATAGCCACCTCCCTGTGGAGAGGACAC
TTAGGGTCCCCTCCCCTGGTCTTGTTACCTGTGTGTGTGCTGGTGCTGCGCATGAGGACTGTCTGCCTTTGAGGGCTTGGGCAGCAGCGGCAGCCATCTTGGTTTTAGGAAATGGGGCCGCCTGGCCC
AGCCACTCACTGGTGTCCTGTCTCTTGTCGTCCTGTCCTTCCTATCTCCCCAAAGTACCATAGCCAGTTTCCAGATGGGCCACAGACTGGGGAGGAGAATCAGTGGCCCAGCCAGAAGTTAAAGGGCT
GAGGGTTGAGGTGAGAGGCACCTCTGCTCTTGTTGGGAGGGGTGGCTGCTTGGAAATAGGCCCAGGGGCTCTGCCAGCCTCGGCCTCTCCCTCCTGAGTTGCCTTCTGTTGGTGGCTTTCTTCTTGAA
CCCACCTGTGTAAAGAGGTTTTCAGTTCCGTGGGTTTCCCCTTTGATTCTGTAAATAGTCCCAGAGAGAATTCGTGGGCTGAGGGCAATTCTGTCTTGGAGGAAGAAGCTGGACATTCAGCCTGTGGA
GTCTGAGTTTTGAAGGATGTAGGGAGCCTTAGTTGGGTCTCAGACCATAAGTGTGTACTACACAGAAGCTGTGTTTTCTAGTTCTGGTCTGCTGTTGAGATGTTTGGTAAATGCCAGGTTGATAGGGC
GCTGGCTGCTTGGAGCAAAGGGTGCATTTCAGGGTGTGGCCACCAGGTGCTGTGAGTTTCTGTGGCTCATGGCCTCTGGGCTGGTCCCTTGCACAGGGCCCACGCTGGAGTCTTACCACTCTGCTGCA
GGGGTGGAAGGTGGCCCCTCTTGTCACCCATACCCATTTCTTACAAAATAAGTTACACCGAGTCTACTTGGCCCTAGAAGAGAAAGTTGAAGAGTCCCAGACCTACTAGCATTTTGCAACTATGCTTG
TAAAGTCCTCGGAAAGTTTCCTCGCGTACCAGACAGCGGCGGGGGCTGATAGCAATTTTAGTTTTTGGCCTCCCTATCCTCTCACATGAGAACACTGCCTGGATGCATCTCATGATCTCTGGAGAATT
TCCCCATCTTTCTCTTCTTTCCATCGTGTGGATTCAATAGTGTGGATTTGAAGGCTGCCCTGCCCCCGACTCTCCTGCCGCACCCCTGGCCATTGTACCTTTTGATGTTTAGAAGTTCGTGGAAGTAG
ACGCTGAGGTGTGCAGAGGAGCTGGTGGATAACAGAGAATGCCAGGGAAGATGAGTGCTGGGTCAGGGTACTTGGATGAAACGGTGCAGGCCAGGCGGGCCCTAATAAAACCCTCTGCCAGGTCTGGG
AGTCCCAGGCCATCTGCTCAACGCTCTGTGGTTTGTCAGACCTGCAAGCAAGCCCCCTGCTGGGGAAGCCTAGGTGTCCTTGAGCTGAACCGCACTGAAGAACTCTTGTCCTCACTGGCTGATGCAGC
AGAACTCTTGGGAAATGTCTTAGTCCTGCAGAATCAGGAGTCACCAGATGATGCAGAGTTGAGATCATCATTGCAAAGTTCTCTGTTCCTGAGGAACTAAATTTAAGGAAAAAATGGGATTTTGTTTT
AGAGTTGGAAAAAAAGCCTGATTAAAGAGTTTCTGCCTGTTCA

hide sequence

RefSeq Acc Id:

XM_005273733 ⟹ XP_005273790

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,066,300 - 65,084,040 (-)	NCBI
GRCh37	11	64,833,772 - 64,851,635 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCA
AAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACT
GAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTGTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAG
TGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGGTGTGCGGGCAGCCATGGCAGCGGGGAGGGAAGAGGCGGCTGCCCCATGCTGCTCACTCGAGCTGTCTCTGCCTGC
AGTGACCCAAACCCCCGGAAGGCAGGTCTCCTCTTCAAGCTGCCTGACCTGCCCCACGACCACAGAGACCAGGGTCAGGCCTGGCCAGGCCCCAGGCCAGAGGTCGGACACCTCCTCGGGAGGCCGCT
CCTTCAGCCAGCTCCTCCCTAGATCCCAGAAATAAACTTGGAAGCTAAGCTT

hide sequence

RefSeq Acc Id:

XM_005273734 ⟹ XP_005273791

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,066,300 - 65,084,040 (-)	NCBI
GRCh37	11	64,833,772 - 64,851,635 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCA
AAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACT
GAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTGTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAG
TGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGTGACCCAAACCCCCGGAAGGCAGGTCTCCTCTTCAAGCTGCCTGACCTGCCCCACGACCACAGAGACCAGGGTCAG
GCCTGGCCAGGCCCCAGGCCAGAGGTCGGACACCTCCTCGGGAGGCCGCTCCTTCAGCCAGCTCCTCCCTAGATCCCAGAAATAAACTTGGAAGCTAAGC

hide sequence

RefSeq Acc Id:

XM_011544743 ⟹ XP_011543045

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,061,093 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTGGAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCA
GCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGCTCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAA
AGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCGCAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACT
AAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACCCTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAA
AGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGCCGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGG
TGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCTCCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTG
TCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTGAGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGA
ACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCAAAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCC
CCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACTGAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTG
TATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAGTGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGGGAGACAACAGC
CAAGAGGATGGAAATTCAGGGCTGCTTGAGTGTCTTCACAACATGGTGTCCGGGAGGCCACGTGACTCTGCAGGCACATCCAGGGGCAAGGGTGCAGGCGCAGAAGAAGCAGAAAGTGAGTCAGAAGT
AACCAGAATGGTGTTTTCCCAGTGGATGTGACCAAAGCAGAGAGGATTGGGGGTTAAGAGGGCTTCCAGGGCCTCAAACTGGGCAA

hide sequence

RefSeq Acc Id:

XM_011544747 ⟹ XP_011543049

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,066,300 - 65,084,040 (-)	NCBI

Sequence:

show sequence

TTCCGAGGGCCGCAGACCGCTAGCCCTACGTCACTTCCGCTTCCTTTCCCGCAGGGCGGGTAATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTGGAG
GAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGCTCT
GAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCGCAG
GAGCCCTAGGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTGAGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCAC
CTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCAAAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAG
GACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACTGAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCC
CACCTTATTGTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAGTGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGGT
GTGCGGGCAGCCATGGCAGCGGGGAGGGAAGAGGCGGCTGCCCCATGCTGCTCACTCGAGCTGTCTCTGCCTGCAGTGACCCAAACCCCCGGAAGGCAGGTCTCCTCTTCAAGCTGCCTGACCTGCCC
CACGACCACAGAGACCAGGGTCAGGCCTGGCCAGGCCCCAGGCCAGAGGTCGGACACCTCCTCGGGAGGCCGCTCCTTCAGCCAGCTCCTCCCTAGATCCCAGAAATAAACTTGGAAGCTAAGCTTCA
GCTTCACCAAGTGTCTGTGGGCCCTGGGCTCAGGTGGGGAGCAGGAGGTCACCACGTCCACACT

hide sequence

RefSeq Acc Id:

XM_011544748 ⟹ XP_011543050

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,067,661 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGTCACCTTGGCGCTTTCTCTGCAAAGCCACCTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCT
GAACACCTCTGAGCCCACTGAGCCAAAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATG
ACTG

hide sequence

RefSeq Acc Id:

XM_011544749 ⟹ XP_011543051

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,066,572 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGGCTTCGGGAGTCACTGAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATT
GTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAGTGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTG

hide sequence

RefSeq Acc Id:

XM_017017158 ⟹ XP_016872647

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,065,035 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTGGAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCA
GCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGCTCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAA
AGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCGCAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACT
AAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACCCTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAA
AGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGCCGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGG
TGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCTCCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTG
TCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTGAGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGA
ACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCAAAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCC
CCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACTGAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTG
TATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAGTGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGCATCTAGGTCTA
ATGGATGGTAAAAGATCCACCATGCAGAATTCCTTCGTTAATCCTCGTGTGACACGGAACGGGCTGGGGATGATCATTTTGCCTTATGTTCACTGTAGGGAGACAACAGCCAAGAGGATGGAAATTCA
G

hide sequence

RefSeq Acc Id:

XM_054367584 ⟹ XP_054223559

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,059,580 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367585 ⟹ XP_054223560

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,059,581 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367586 ⟹ XP_054223561

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,054,375 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367587 ⟹ XP_054223562

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,058,315 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367588 ⟹ XP_054223563

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,059,506 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367589 ⟹ XP_054223564

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,060,941 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XM_054367590 ⟹ XP_054223565

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,059,852 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XR_001747757

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,062,702 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCA
AAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACT
GAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTGTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAG
TGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGGGAGACAACAGCCAAGAGGATGGAAATTCAGCCTGGGACAGCGCTCGAATAAGGTTACATGAATACTGCTTGGCTG
CAGGAAATGGAGTCTATTACGGAGCCCCCTCCCCAACCAGCTCCAAACCACAGAAGTGCTTATAGATTCGAATGCATCCTGGCCATGGTTCTGCAGCTCAGGGATCCTTCACTGGCTGTCCTGAGGCT
GGTCTTGAACTTCTGGACTCAAGCGATCTTCCTG

hide sequence

RefSeq Acc Id:

XR_001747758

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,062,702 - 65,084,040 (-)	NCBI

Sequence:

show sequence

AATTCGAACGTTTTTTGCAGCGAGTGGCCTTCCCGGTTGGCGCGCGCCCGGGGCGGCGGCGCTG
GAGGAGCTCGAGACGGAGCCTAAGTTATGTCTGGGAGGCGAACGCGGTCCGGAGGAGCCGCTCAGCGCTCCGGGCCAAGGGCCCCATCTCCTACTAAGCCTCTGCGGAGGTCCCAGCGGAAATCAGGC
TCTGAACTCCCGAGCATCCTCCCTGAAATCTGGCCGAAGACACCCAGTGCGGCTGCAGTCAGAAAGCCCATCGTCTTAAAGAGGATCGTGGCCCATGCTGTAGAGGTCCCAGCTGTCCAATCACCTCG
CAGGAGCCCTAGGATTTCCTTTTTCTTGGAGAAAGAAAACGAGCCCCCTGGCAGGGAGCTTACTAAGGAGGACCTTTTCAAGACACACAGCGTCCCTGCCACCCCCACCAGCACTCCTGTGCCGAACC
CTGAGGCCGAGTCCAGCTCCAAGGAAGGAGAGCTGGACGCCAGAGACTTGGAAATGTCTAAGAAAGTCAGGCGTTCCTACAGCCGGCTGGAGACCCTGGGCTCTGCCTCTACCTCCACCCCAGGCCGC
CGGTCCTGCTTTGGCTTCGAGGGGCTGCTGGGGGCAGAAGACTTGTCCGGAGTCTCGCCAGTGGTGTGCTCCAAACTCACCGAGGTCCCCAGGGTTTGTGCAAAGCCCTGGGCCCCAGACATGACTCT
CCCTGGAATCTCCCCACCACCCGAGAAACAGAAACGTAAGAAGAAGAAAATGCCAGAGATCTTGTCTCTTAGGGGCAGACAAAGAGCCCACTCCAAGCTGGCCAACAAGCCAGTGGTGCAGCCTGTTG
AGGAGCAAGAACCCAAGGGCCCTCAGGCTTCCGAGGAGCGGAACTTGGAGCCACCTTCCTCAGAACAACTGGAACCCACCGTCACGTTCCTGTTTACACTCCTGAACACCTCTGAGCCCACTGAGCCA
AAAGACCCTGAATCGGACTCGGAGATCCAGGAGTACCAGTTCTTAGATCAGGAGGACTGGGGCCCCCAGCGGACCTCAAAGGAGATCAGGCAGTTGCAGAATGACTGCATGAGGCTTCGGGAGTCACT
GAACACCACCCAAGTGCACAACCTGGCCCTGGGGGAGAAGCTGCAGAACCTGCCCACCTTATTGTATAAGAGCCTGAAGGAGGGAGCCCAGGCCATCCAGGAGGAGGCCCAGGCCATCCAGGATGAAG
TGAAGGCCCTGCAGGAGGAAAGCCAGGCCCTGCCGGAGGTGGCTCTGCTCAGCCTGGGACAGCGCTCGAATAAGGTTACATGAATACTGCTTGGCTGCAGGAAATGGAGTCTATTACGGAGCCCCCTC
CCCAACCAGCTCCAAACCACAGAAGTGCTTATAGATTCGAATGCATCCTGGCCATGGTTCTGCAGCTCAGGGATCCTTCACTGGCTGTCCTGAGGCTGGTCTTGAACTTCTGGACTCAAGCGATCTTC
CTG

hide sequence

RefSeq Acc Id:

XR_008488336

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,055,983 - 65,077,318 (-)	NCBI

RefSeq Acc Id:

XR_008488337

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	65,055,983 - 65,077,318 (-)	NCBI


Protein RefSeqs	NP_001420447	(Get FASTA)	NCBI Sequence Viewer
	NP_542399	(Get FASTA)	NCBI Sequence Viewer
	XP_005273790	(Get FASTA)	NCBI Sequence Viewer
	XP_005273791	(Get FASTA)	NCBI Sequence Viewer
	XP_011543045	(Get FASTA)	NCBI Sequence Viewer
	XP_011543049	(Get FASTA)	NCBI Sequence Viewer
	XP_011543050	(Get FASTA)	NCBI Sequence Viewer
	XP_011543051	(Get FASTA)	NCBI Sequence Viewer
	XP_016872647	(Get FASTA)	NCBI Sequence Viewer
	XP_054223559	(Get FASTA)	NCBI Sequence Viewer
	XP_054223560	(Get FASTA)	NCBI Sequence Viewer
	XP_054223561	(Get FASTA)	NCBI Sequence Viewer
	XP_054223562	(Get FASTA)	NCBI Sequence Viewer
	XP_054223563	(Get FASTA)	NCBI Sequence Viewer
	XP_054223564	(Get FASTA)	NCBI Sequence Viewer
	XP_054223565	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH11000	(Get FASTA)	NCBI Sequence Viewer
	BAE46873	(Get FASTA)	NCBI Sequence Viewer
	BAF84179	(Get FASTA)	NCBI Sequence Viewer
	BAG52747	(Get FASTA)	NCBI Sequence Viewer
	EAW74342	(Get FASTA)	NCBI Sequence Viewer
	EAW74343	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000275517
	ENSP00000275517.3
GenBank Protein	Q96FF9	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_542399 ⟸ NM_080668

- UniProtKB:

Q96FF9 (UniProtKB/Swiss-Prot), A8K625 (UniProtKB/Swiss-Prot), B5MBX0 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MSGRRTRSGGAAQRSGPRAPSPTKPLRRSQRKSGSELPSILPEIWPKTPSAAAVRKPIVLKRIVAHAVEVPAVQSPRRSPRISFFLEKENEPPGRELTKEDLFKTHSVPATPTSTPVPNPEAESSSKE
GELDARDLEMSKKVRRSYSRLETLGSASTSTPGRRSCFGFEGLLGAEDLSGVSPVVCSKLTEVPRVCAKPWAPDMTLPGISPPPEKQKRKKKKMPEILKTELDEWAAAMNAEFEAAEQFDLLVE

hide sequence

RefSeq Acc Id:

XP_005273790 ⟸ XM_005273733

- Peptide Label:

isoform X1

- Sequence:

show sequence

MSGRRTRSGGAAQRSGPRAPSPTKPLRRSQRKSGSELPSILPEIWPKTPSAAAVRKPIVLKRIVAHAVEVPAVQSPRRSPRISFFLEKENEPPGRELTKEDLFKTHSVPATPTSTPVPNPEAESSSKE
GELDARDLEMSKKVRRSYSRLETLGSASTSTPGRRSCFGFEGLLGAEDLSGVSPVVCSKLTEVPRVCAKPWAPDMTLPGISPPPEKQKRKKKKMPEILSLRGRQRAHSKLANKPVVQPVEEQEPKGPQ
ASEERNLEPPSSEQLEPTVTFLFTLLNTSEPTEPKDPESDSEIQEYQFLDQEDWGPQRTSKEIRQLQNDCMRLRESLNTTQVHNLALGEKLQNLPTLLYKSLKEGAQAIQEEAQAIQDEVKALQEESQ
ALPEVALLRCAGSHGSGEGRGGCPMLLTRAVSACSDPNPRKAGLLFKLPDLPHDHRDQGQAWPGPRPEVGHLLGRPLLQPAPP

hide sequence

RefSeq Acc Id:

XP_005273791 ⟸ XM_005273734

- Peptide Label:

isoform X2

- Sequence:

show sequence

MSGRRTRSGGAAQRSGPRAPSPTKPLRRSQRKSGSELPSILPEIWPKTPSAAAVRKPIVLKRIVAHAVEVPAVQSPRRSPRISFFLEKENEPPGRELTKEDLFKTHSVPATPTSTPVPNPEAESSSKE
GELDARDLEMSKKVRRSYSRLETLGSASTSTPGRRSCFGFEGLLGAEDLSGVSPVVCSKLTEVPRVCAKPWAPDMTLPGISPPPEKQKRKKKKMPEILSLRGRQRAHSKLANKPVVQPVEEQEPKGPQ
ASEERNLEPPSSEQLEPTVTFLFTLLNTSEPTEPKDPESDSEIQEYQFLDQEDWGPQRTSKEIRQLQNDCMRLRESLNTTQVHNLALGEKLQNLPTLLYKSLKEGAQAIQEEAQAIQDEVKALQEESQ
ALPEVALLSDPNPRKAGLLFKLPDLPHDHRDQGQAWPGPRPEVGHLLGRPLLQPAPP

hide sequence

RefSeq Acc Id:

XP_011543045 ⟸ XM_011544743

- Peptide Label:

isoform X3

- Sequence:

show sequence

MSGRRTRSGGAAQRSGPRAPSPTKPLRRSQRKSGSELPSILPEIWPKTPSAAAVRKPIVLKRIV
AHAVEVPAVQSPRRSPRISFFLEKENEPPGRELTKEDLFKTHSVPATPTSTPVPNPEAESSSKEGELDARDLEMSKKVRRSYSRLETLGSASTSTPGRRSCFGFEGLLGAEDLSGVSPVVCSKLTEVP
RVCAKPWAPDMTLPGISPPPEKQKRKKKKMPEILSLRGRQRAHSKLANKPVVQPVEEQEPKGPQASEERNLEPPSSEQLEPTVTFLFTLLNTSEPTEPKDPESDSEIQEYQFLDQEDWGPQRTSKEIR
QLQNDCMRLRESLNTTQVHNLALGEKLQNLPTLLYKSLKEGAQAIQEEAQAIQDEVKALQEESQALPEVALLRETTAKRMEIQGCLSVFTTWCPGGHVTLQAHPGARVQAQKKQKVSQK

hide sequence

RefSeq Acc Id:

XP_011543049 ⟸ XM_011544747

- Peptide Label:

isoform X5

- Sequence:

show sequence

MSGRRTRSGGAAQRSGPRAPSPTKPLRRSQRKSGSELPSILPEIWPKTPSAAAVRKPIVLKRIVAHAVEVPAVQSPRRSPRSLRGRQRAHSKLANKPVVQPVEEQEPKGPQASEERNLEPPSSEQLEP
TVTFLFTLLNTSEPTEPKDPESDSEIQEYQFLDQEDWGPQRTSKEIRQLQNDCMRLRESLNTTQVHNLALGEKLQNLPTLLYKSLKEGAQAIQEEAQAIQDEVKALQEESQALPEVALLRCAGSHGSG
EGRGGCPMLLTRAVSACSDPNPRKAGLLFKLPDLPHDHRDQGQAWPGPRPEVGHLLGRPLLQPAPP

hide sequence

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q96FF9-F1-model_v2	AlphaFold	Q96FF9	1-252	view protein structure

RGD ID:

6788618

Promoter ID:

HG_KWN:13299

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4

Transcripts:

ENST00000404147, NM_006782, OTTHUMT00000318028, OTTHUMT00000318029, OTTHUMT00000318030, UC009YQA.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	11	64,607,421 - 64,608,312 (-)	MPROMDB

RGD ID:

7220969

Promoter ID:

EPDNEW_H16230

Type:

initiation region

Name:

CDCA5_1

Description:

cell division cycle associated 5

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H16233 EPDNEW_H16231

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,084,040 - 65,084,100	EPDNEW

RGD ID:

7220975

Promoter ID:

EPDNEW_H16231

Type:

initiation region

Name:

CDCA5_3

Description:

cell division cycle associated 5

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H16230 EPDNEW_H16233

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,084,174 - 65,084,234	EPDNEW

RGD ID:

7220973

Promoter ID:

EPDNEW_H16233

Type:

initiation region

Name:

CDCA5_2

Description:

cell division cycle associated 5

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H16230 EPDNEW_H16231

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	65,084,413 - 65,084,473	EPDNEW

Database	Acc Id	Source(s)
COSMIC	CDCA5	COSMIC
Ensembl Genes	ENSG00000146670	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000275517	ENTREZGENE
	ENST00000275517.8	UniProtKB/Swiss-Prot
GTEx	ENSG00000146670	GTEx
HGNC ID	HGNC:14626	ENTREZGENE
Human Proteome Map	CDCA5	Human Proteome Map
InterPro	Sororin	UniProtKB/Swiss-Prot
KEGG Report	hsa:113130	UniProtKB/Swiss-Prot
NCBI Gene	CDCA5	ENTREZGENE
OMIM	609374	OMIM
PANTHER	PTHR31092	UniProtKB/Swiss-Prot
	SORORIN	UniProtKB/Swiss-Prot
Pfam	Sororin	UniProtKB/Swiss-Prot
PharmGKB	PA26278	PharmGKB
UniProt	A8K625	ENTREZGENE
	B5MBX0	ENTREZGENE, UniProtKB/TrEMBL
	CDCA5_HUMAN	UniProtKB/Swiss-Prot
	H0YCL8_HUMAN	UniProtKB/TrEMBL
	H0YCR8_HUMAN	UniProtKB/TrEMBL
	H0YCT9_HUMAN	UniProtKB/TrEMBL
	H0YCZ9_HUMAN	UniProtKB/TrEMBL
	Q96FF9	ENTREZGENE
UniProt Secondary	A8K625	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Human Phenotype Annotations - ClinVar